| EPB238 | Temporal trends of pediatric HIV drug resistance and subtype in Brazil (2009-2020) | E-poster | Resistance to ART |
| EPC022 | Temporal trends of pediatric HIV infection due to mother-to-child transmission in the state of São Paulo - Brazil, 1987-2020 | E-poster | Epidemiology of HIV in infants and children |
| OAA0405 | Temsavir treatment of HIV-1-infected cells decreases envelope glycoproteins recognition by broadly-neutralizing antibodies | Oral abstract session with live Q&A | Immunotherapy (including broadly neutralizing antibodies) |
| EPC156 | Testing strategies to achieve the goal of 95% knowledge of status by 2025 | E-poster | Modelling the impact of service models on the HIV epidemic |
| OAE0405 | Thailand national PrEP program: moving towards sustainability | Oral abstract session with live Q&A | Implementation science of scaling up prevention (including PrEP) |
| EPD234 | Thandizo mobile app: improved ART adherence, knowledge and leadership among young people living with HIV in Malawi | E-poster | Community-based approaches (including empowerment, outreach and service delivery) |
| EPB207 | The 'magic bullet' for HIV viral suppression? How fixed-dose combination Dolutegravir (DTG) antiretrovirals are improving viral suppression among children aged 10-14 years on antiretroviral therapy (ART) in Zambia | E-poster | ARV management strategies in paediatric and adolescent populations |
| OAC0302 | The 95-95-95 UNAIDS targets mask the underlying number of people with transmissible viral load: case study of England | Oral abstract session with live Q&A | Monitoring and evaluation of health systems along the HIV cascade |
| EPE025 | The acceptability of pharmacy-based HIV PrEP delivery among private pharmacy clients in Kenya: findings from a pilot study | E-poster | Implementation science of scaling up prevention (including PrEP) |
| PESAB11 | The acceptability of the AMBITION treatment regimen for HIV-associated cryptococcal meningitis: findings from a qualitative study of patients and providers in Botswana and Uganda | Poster exhibition | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |